Cargando…

Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis

BACKGROUND: To date, various treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP) have been reported. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of current treatments for RP-CME. METHODS: PubMed, Embase and the Cochrane library were sear...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chen, Liu, Xia, Peng, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149278/
https://www.ncbi.nlm.nih.gov/pubmed/35652079
http://dx.doi.org/10.3389/fmed.2022.895208
_version_ 1784717175354818560
author Chen, Chen
Liu, Xia
Peng, Xiaoyan
author_facet Chen, Chen
Liu, Xia
Peng, Xiaoyan
author_sort Chen, Chen
collection PubMed
description BACKGROUND: To date, various treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP) have been reported. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of current treatments for RP-CME. METHODS: PubMed, Embase and the Cochrane library were searched from inception to August 2021. ClinicalTrials.gov, WHO ICTRP and ISRCTN were also searched for relevant studies. Only studies published in English were included. The RoB 2 tool was used to evaluate the risk of bias of randomized controlled trials (RCTs), and the MINORS scale was used to assess the methodological quality of non-RCTs. Review manager (Revman) was used to pool the data. The primary outcomes included the change of central macular thickness (CMT) and best-corrected visual acuity (BCVA) from baseline. The secondary outcomes included fluorescein angiography (FA) leakage, rebound of CME and adverse effects. RESULTS: Thirty-two studies were included in the current systematic review and 7 studies were used for meta-analysis. Treatments for RP-CME included oral and topical carbonic anhydrase inhibitors (CAIs), systematic and local steroids, anti-VEGF therapy, NSAIDS, grid LASER photocoagulation, subliminal micropulse LASER, vitrectomy, lutein supplement and oral minocycline. CAIs and local steroids were proved to be effective in reducing CMT. The effects of anti-VEGF reagents varied among studies. Regarding other treatments, only one study for each method fitted the inclusion criteria, so the evidence was very limited. CONCLUSION: Topical CAIs, oral CAIs and local steroids are effective in treating RP-CME. However, due to the overall inferior design and small patient number of the included studies, the quality of evidence was poor. Systematic steroids, LASER, NSAIDS and vitrectomy may also be effective, nevertheless, considering the limited number of studies, no conclusion could be drawn regarding these treatments. More well-designed and conducted studies are needed in this field. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021273979, identifier CRD42021273979.
format Online
Article
Text
id pubmed-9149278
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91492782022-05-31 Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis Chen, Chen Liu, Xia Peng, Xiaoyan Front Med (Lausanne) Medicine BACKGROUND: To date, various treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP) have been reported. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of current treatments for RP-CME. METHODS: PubMed, Embase and the Cochrane library were searched from inception to August 2021. ClinicalTrials.gov, WHO ICTRP and ISRCTN were also searched for relevant studies. Only studies published in English were included. The RoB 2 tool was used to evaluate the risk of bias of randomized controlled trials (RCTs), and the MINORS scale was used to assess the methodological quality of non-RCTs. Review manager (Revman) was used to pool the data. The primary outcomes included the change of central macular thickness (CMT) and best-corrected visual acuity (BCVA) from baseline. The secondary outcomes included fluorescein angiography (FA) leakage, rebound of CME and adverse effects. RESULTS: Thirty-two studies were included in the current systematic review and 7 studies were used for meta-analysis. Treatments for RP-CME included oral and topical carbonic anhydrase inhibitors (CAIs), systematic and local steroids, anti-VEGF therapy, NSAIDS, grid LASER photocoagulation, subliminal micropulse LASER, vitrectomy, lutein supplement and oral minocycline. CAIs and local steroids were proved to be effective in reducing CMT. The effects of anti-VEGF reagents varied among studies. Regarding other treatments, only one study for each method fitted the inclusion criteria, so the evidence was very limited. CONCLUSION: Topical CAIs, oral CAIs and local steroids are effective in treating RP-CME. However, due to the overall inferior design and small patient number of the included studies, the quality of evidence was poor. Systematic steroids, LASER, NSAIDS and vitrectomy may also be effective, nevertheless, considering the limited number of studies, no conclusion could be drawn regarding these treatments. More well-designed and conducted studies are needed in this field. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021273979, identifier CRD42021273979. Frontiers Media S.A. 2022-05-16 /pmc/articles/PMC9149278/ /pubmed/35652079 http://dx.doi.org/10.3389/fmed.2022.895208 Text en Copyright © 2022 Chen, Liu and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chen, Chen
Liu, Xia
Peng, Xiaoyan
Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
title Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
title_full Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
title_fullStr Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
title_full_unstemmed Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
title_short Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
title_sort management of cystoid macular edema in retinitis pigmentosa: a systematic review and meta-analysis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149278/
https://www.ncbi.nlm.nih.gov/pubmed/35652079
http://dx.doi.org/10.3389/fmed.2022.895208
work_keys_str_mv AT chenchen managementofcystoidmacularedemainretinitispigmentosaasystematicreviewandmetaanalysis
AT liuxia managementofcystoidmacularedemainretinitispigmentosaasystematicreviewandmetaanalysis
AT pengxiaoyan managementofcystoidmacularedemainretinitispigmentosaasystematicreviewandmetaanalysis